Search Results 791-800 of 17252 for lupus

1. Shared Biorepository for the Investigation of Inflammatory Arthritis at Mayo Clinic and University of Massachusetts

   The purpose of this study is to establish a comparator cohort of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and other ...

2. Rituximab Vasculitis Maintenance Study - Mayo Clinic

   Presence of another multisystem autoimmune disease, including Churg Strauss syndrome, systemic lupus erythematosus, anti-GBM disease, or cryoglobulinaemic ...

3. A Study to Evaluate the Effectiveness, Safety and Way in Which the Body Processes REGN3500 in Adults with Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

   ... lupus, inflammatory bowel disease, rheumatoid arthritis, etc.), other severe endocrinological, gastrointestinal, metabolic, pulmonary, or lymphatic diseases ...

4. Claudia F. Lucchinetti, M.D. - Mayo Clinic Faculty Profiles

   Claudia F. Lucchinetti, M.D., investigates the immunopathology and pathogenesis of multiple sclerosis, neuromyelitis optica and other CNS inflammatory ...

5. A Study to Evaluate the Safety, PK/​PD of (OriCAR-017) in Subjects With RR/​MM - RIGEL Study - Mayo Clinic

   History of autoimmune diseases (such as Crohn's disease, rheumatoid arthritis, systemic lupus erythematosus) caused damage to terminal organs or required ...

6. A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia - Mayo Clinic

   lupus anticoagulant) 8. Prior history of complications of ascites in the past 6 months including: 1. Spontaneous bacterial peritonitis 2. Hepatic ...

7. Safety Study of SEA-CD40 in Cancer Patients - Mayo Clinic

   Any known or suspected active organ-threatening autoimmune disease, such as inflammatory bowel disease, autoimmune hepatitis, lupus, or pneumonitis. Women ...

8. Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

   ... lupus erythematosus, multiple sclerosis, etc.) within 2 months before V1 or 5 half-lives, whichever is longer. Any experimental monoclonal antibody (mAB) ...

9. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   Autoimmune diseases include, but not limited to, lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, antiphospholipid syndrome, Wegener's ...

10. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

    - Contraindication to radiation therapy including: prior ipsilateral breast or mantle RT, active scleroderma, systemic lupus erythematosis and pregnancy. -- ...